On 2025-05-14, Verve Therapeutics, Inc. (VERV) announced earnings per share of $-0.35 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.71.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.69 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.71 | $-0.35 |
| 2025-02-27 | 2024-12-31 | $-0.72 | $-0.58 |
| 2024-11-05 | 2024-09-30 | $-0.70 | $-0.59 |
| 2024-08-08 | 2024-06-30 | $-0.68 | $-0.59 |
| 2024-05-08 | 2024-03-31 | $-0.68 | $-0.59 |
| 2024-02-27 | 2023-12-31 | $-0.80 | $-0.69 |
| 2023-11-07 | 2023-09-30 | $-0.91 | $-0.72 |
| 2023-08-10 | 2023-06-30 | $-0.91 | $-0.87 |
| 2023-05-15 | 2023-03-31 | $-0.78 | $-0.84 |
| 2023-03-02 | 2022-12-31 | $-0.76 | $-0.67 |
| 2022-11-07 | 2022-09-30 | $-0.75 | $-0.79 |
| 2022-08-09 | 2022-06-30 | $-0.63 | $-0.84 |
| 2022-05-10 | 2022-03-31 | $-0.63 | $-0.62 |
| 2022-03-14 | 2021-12-31 | $-0.54 | $-0.65 |
| 2021-11-10 | 2021-09-30 | $-0.45 | $-0.47 |
| 2021-08-12 | 2021-06-30 | $-0.53 | $-2.13 |